Clinical features of anti-FH auto antibodies-associated HUS: A typical onset but an atypical outcome
Marie‐Agnès Dragon‐Durey(Centre de Recherche des Cordeliers), Pankaj Hari(Indian Council of Medical Research), Nobuaki Takagi(Hyogo Medical University), S. Sethi(All India Institute of Medical Sciences), Bruno Ranchin(Hospices Civils de Lyon), Jacques Blouin(Hôpital Européen), Arvind Bagga(All India Institute of Medical Sciences), Hae II Cheong(Seoul National University Children's Hospital), Jean-Luc André(Hôpital d'Enfants), Caroline Blanc(Université Claude Bernard Lyon 1)
Cited by 0
Related Papers
Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome
|Journal of the American Society of Nephrology|2004|415
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203